.FDA denies experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Permit MDMA Therapy, Seeking More Research Study The New York City TimesFDA Rejects Ecstasy-Based Medication The Exchange JournalFDA declines to accept unique MDMA therapy to treat post-traumatic stress disorder, with ask for more hearing data CNNFDA declines initially psychedelic to treat post-traumatic stress disorder, calling for additional study The Washington Blog post.